Tissue-resident ecto-5′ nucleotidase (CD73) regulates leukocyte trafficking in the ischemic brain

Journal of Immunology

Volumn 188, Issue 5, 2012, Pages 2387-2398

  Petrovic Djergovic, Danica ^a   Hyman, Matthew C ^b   Ray, Jessica J ^b   Bouis, Diane ^b   Visovatti, Scott H ^b   Hayasaki, Takanori ^b   Pinsky, David J ^b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; B7 ANTIGEN; CD86 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PROTECTION; CELL TRANSPORT; CHIMERA; CONTROLLED STUDY; ENGRAFTMENT; IRRADIATION; LEUKOCYTE; MACROPHAGE; MALE; MICROGLIA; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; UPREGULATION; WILD TYPE;

5'-NUCLEOTIDASE; ADENOSINE; ANIMALS; BONE MARROW TRANSPLANTATION; BRAIN EDEMA; BRAIN ISCHEMIA; CELL MOVEMENT; EXTRACELLULAR FLUID; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 84857491702     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003671     Document Type: Article

References (46)

1. Lindsberg, P. J., and A. J. Grau. 2003. Inflammation and infections as risk factors for ischemic stroke. Stroke 34: 2518-2532. (Pubitemid 37221976)
2. Ross, D. T., and F. F. Ebner. 1990. Thalamic retrograde degeneration following cortical injury: an excitotoxic process? Neuroscience 35: 525-550. (Pubitemid 20198388)
3. Huang, J., L. J. Kim, R. Mealey, H. C. Marsh, Jr., Y. Zhang, A. J. Tenner, E. S. Connolly, Jr. and D. J. Pinsky. 1999. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 285: 595-599.
4. Braun, N., C. Lenz, F. Gillardon, M. Zimmermann, and H. Zimmermann. 1997. Focal cerebral ischemia enhances glial expression of ecto-5′- nucleotidase. Brain Res. 766: 213-226. (Pubitemid 27431452)
5. Salmi, M., and S. Jalkanen. 2005. Cell-surface enzymes in control of leukocyte trafficking. Nat. Rev. Immunol. 5: 760-771. (Pubitemid 41400850)
6. Pinsky, D. J., M. J. Broekman, J. J. Peschon, K. L. Stocking, T. Fujita, R. Ramasamy, E. S. Connolly, Jr., J. Huang, S. Kiss, Y. Zhang, et al. 2002. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J. Clin. Invest. 109: 1031-1040. (Pubitemid 34408578)
7. Latini, S., and F. Pedata. 2001. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 79: 463-484. (Pubitemid 33029920)
8. Su, E. J., L. Fredriksson, M. Geyer, E. Folestad, J. Cale, J. Andrae, Y. Gao, K. Pietras, K. Mann, M. Yepes, et al. 2008. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat. Med. 14: 731-737.
9. Thompson, L. F., H. K. Eltzschig, J. C. Ibla, C. J. Van De Wiele, R. Resta, J. C. Morote-Garcia, and S. P. Colgan. 2004. Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200: 1395-1405. (Pubitemid 39657287)
10. Hata, R., G. Mies, C. Wiessner, K. Fritze, D. Hesselbarth, G. Brinker, and K. A. Hossmann. 1998. A reproducible model of middle cerebral artery occlusion in mice: hemodynamic, biochemical, and magnetic resonance imaging. J. Cereb. Blood Flow Metab. 18: 367-375. (Pubitemid 28166511)
11. Day, S. M., J. L. Reeve, B. Pedersen, D. M. Farris, D. D. Myers, M. Im, T. W. Wakefield, N. Mackman, and W. P. Fay. 2005. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood 105: 192-198. (Pubitemid 40053082)
12. Fux, M., N. van Rooijen, and T. Owens. 2008. Macrophage-independent T cell infiltration to the site of injury-induced brain inflammation. J. Neuroimmunol. 203: 64-72.
13. Németh, Z. H., C. S. Lutz, B. Csóka, E. A. Deitch, S. J. Leibovich, W. C. Gause, M. Tone, P. Pacher, E. S. Vizi, and G. Haskó. 2005. Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism. J. Immunol. 175: 8260-8270. (Pubitemid 41798391)
14. Srinivasan, M., I. E. Gienapp, S. S. Stuckman, C. J. Rogers, S. D. Jewell, P. T. Kaumaya, and C. C. Whitacre. 2002. Suppression of experimental autoimmune encephalomyelitis using peptide mimics of CD28. J. Immunol. 169: 2180-2188. (Pubitemid 34857686)
15. Xia, W., A. R. Hilgenbrink, E. L. Matteson, M. B. Lockwood, J. X. Cheng, and P. S. Low. 2009. A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood 113: 438-446.
16. Colgan, S. P., H. K. Eltzschig, T. Eckle, and L. F. Thompson. 2006. Physiological roles for ecto-59-nucleotidase (CD73). Purinergic Signal. 2: 351-360.
17. Li, X., T. Zhou, X. Zhi, F. Zhao, L. Yin, and P. Zhou. 2006. Effect of hypoxia/reoxygenation on CD73 (ecto-5′-nucleotidase) in mouse microvessel endothelial cell lines. Microvasc. Res. 72: 48-53. (Pubitemid 44118391)
18. Eltzschig, H. K., J. C. Ibla, G. T. Furuta, M. O. Leonard, K. A. Jacobson, K. Enjyoji, S. C. Robson, and S. P. Colgan. 2003. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198: 783-796. (Pubitemid 37087777)
19. Hyman, M. C., D. Petrovic-Djergovic, S. H. Visovatti, H. Liao, S. Yanamadala, D. Bouïs, E. J. Su, D. A. Lawrence, M. J. Broekman, A. J. Marcus, and D. J. Pinsky. 2009. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J. Clin. Invest. 119: 1136-1149.
20. Synnestvedt, K., G. T. Furuta, K. M. Comerford, N. Louis, J. Karhausen, H. K. Eltzschig, K. R. Hansen, L. F. Thompson, and S. P. Colgan. 2002. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110: 993-1002.
21. Sitkovsky, M. V. 2003. Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo. Biochem. Pharmacol. 65: 493-501. (Pubitemid 36144234)
22. Zhang, F., S. Wang, Y. Luo, X. Ji, E. M. Nemoto, and J. Chen. 2009. When hypothermia meets hypotension and hyperglycemia: the diverse effects of adenosine 5′-monophosphate on cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 29: 1022-1034.
23. Suzuki, K., K. Uchida, N. Nakanishi, and Y. Hattori. 2008. Cilostazol activates AMP-activated protein kinase and restores endothelial function in diabetes. Am. J. Hypertens. 21: 451-457. (Pubitemid 351450872)
24. Dirnagl, U., C. Iadecola, and M. A. Moskowitz. 1999. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22: 391-397. (Pubitemid 29453643)
25. Gelderblom, M., F. Leypoldt, K. Steinbach, D. Behrens, C. U. Choe, D. A. Siler, T. V. Arumugam, E. Orthey, C. Gerloff, E. Tolosa, and T. Magnus. 2009. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 40: 1849-1857.
26. Eltzschig, H. K., L. F. Thompson, J. Karhausen, R. J. Cotta, J. C. Ibla, S. C. Robson, and S. P. Colgan. 2004. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 104: 3986-3992. (Pubitemid 39620148)
27. Lennon, P. F., C. T. Taylor, G. L. Stahl, and S. P. Colgan. 1998. Neutrophil-derived 5′-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J. Exp. Med. 188: 1433-1443. (Pubitemid 28489580)
28. Mills, J. H., L. F. Thompson, C. Mueller, A. T. Waickman, S. Jalkanen, J. Niemela, L. Airas, and M. S. Bynoe. 2008. CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 105: 9325-9330.
29. Bouma, M. G., F. A. van den Wildenberg, and W. A. Buurman. 1996. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am. J. Physiol. 270: C522-C529.
30. Henttinen, T., S. Jalkanen, and G. G. Yegutkin. 2003. Adherent leukocytes prevent adenosine formation and impair endothelial barrier function by Ecto-5′-nucleotidase/CD73-dependent mechanism. J. Biol. Chem. 278: 24888-24895. (Pubitemid 37548648)
31. Wang, Q., X. N. Tang, and M. A. Yenari. 2007. The inflammatory response in stroke. J. Neuroimmunol. 184: 53-68. (Pubitemid 46365991)
32. Mordue, D. G., and L. D. Sibley. 2003. A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis. J. Leukoc. Biol. 74: 1015-1025. (Pubitemid 38040323)
33. Hunter, M., Y. Wang, T. Eubank, C. Baran, P. Nana-Sinkam, and C. Marsh. 2009. Survival of monocytes and macrophages and their role in health and disease. Front. Biosci. 14: 4079-4102.
34. Deaglio, S., K. M. Dwyer, W. Gao, D. Friedman, A. Usheva, A. Erat, J. F. Chen, K. Enjyoji, J. Linden, M. Oukka, et al. 2007. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204: 1257-1265. (Pubitemid 46919862)
35. Niemelä, J., I. Ifergan, G. G. Yegutkin, S. Jalkanen, A. Prat, and L. Airas. 2008. IFN-β regulates CD73 and adenosine expression at the blood-brain barrier. Eur. J. Immunol. 38: 2718-2726.
36. Kreckler, L. M., T. C. Wan, Z. D. Ge, and J. A. Auchampach. 2006. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor. J. Pharmacol. Exp. Ther. 317: 172-180.
37. Haskó, G., D. G. Kuhel, J. F. Chen, M. A. Schwarzschild, E. A. Deitch, J. G. Mabley, A. Marton, and C. Szabó . 2000. Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J. 14: 2065-2074.
38. Haskó, G., P. Pacher, E. A. Deitch, and E. S. Vizi. 2007. Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol. Ther. 113: 264-275. (Pubitemid 46149045)
39. Clausen, B. H., K. L. Lambertsen, A. A. Babcock, T. H. Holm, F. Dagnaes-Hansen, and B. Finsen. 2008. Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J. Neuroinflammation 5: 46.
40. Okada, K., T. Fujita, K. Minamoto, H. Liao, Y. Naka, and D. J. Pinsky. 2000. Potentiation of endogenous fibrinolysis and rescue from lung ischemia/reperfusion injury in interleukin (IL)-10-reconstituted IL-10 null mice. J. Biol. Chem. 275: 21468-21476. (Pubitemid 30481850)
41. Liesz, A., E. Suri-Payer, C. Veltkamp, H. Doerr, C. Sommer, S. Rivest, T. Giese, and R. Veltkamp. 2009. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 15: 192-199.
42. Karandikar, N. J., C. L. Vanderlugt, T. Eagar, L. Tan, J. A. Bluestone, and S. D. Miller. 1998. Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. J. Immunol. 161: 192-199. (Pubitemid 28285523)
43. Miller, S. D., C. L. Vanderlugt, D. J. Lenschow, J. G. Pope, N. J. Karandikar, M. C. Dal Canto, and J. A. Bluestone. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3: 739-745. (Pubitemid 26091147)
44. Eri, R., K. N. Kodumudi, D. J. Summerlin, and M. Srinivasan. 2008. Suppression of colon inflammation by CD80 blockade: evaluation in two murine models of inflammatory bowel disease. Inflamm. Bowel Dis. 14: 458-470. (Pubitemid 351571825)
45. Sharpe, A. H., and G. J. Freeman. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2: 116-126. (Pubitemid 37323235)
46. Zernecke, A., K. Bidzhekov, B. Ozüyaman, L. Fraemohs, E. A. Liehn, J. M. Lüscher-Firzlaff, B. Lüscher, J. Schrader, and C. Weber. 2006. CD73/ecto-5′-nucleotidase protects against vascular inflammation and neointima formation. Circulation 113: 2120-2127.